Dynamic CT Myocardial Perfusion Imaging

University of Zurich (UZH)

Status: Terminated

Conditions: Coronary Artery Disease

Treatments: Other: CT-MPI and SPECT-MPI

Study type: Interventional

Funder types: Other

Identifiers

NCT02593838

USZ-2015-0393

Details and patient eligibility

About

This study aims at evaluating the feasibility of CT myocardial perfusion imaging in daily clinical practice and compare it to SPECT perfusion imaging in order to assess sensitivity and specifity of CT myocardial perfusion imaging compared to SPECT.

Full description

If after the clinically indicated CCTA a myocardial perfusion examination is indicated, first a single ultra low dose CT scan will be performed to look for late enhancement of potentially scarred myocardium. Together with the contrast agent co-injection of the clinically indicated tracer 99mTc-Tetrofosmin will be performed for later scintigraphic perfusion evaluation. After stress perfusion imaging CT rest perfusion imaging will be performed in a similar fashion. After acquisition of CT rest perfusion images scintigraphic stress and rest image acquisition will be performed as in daily clinical routine with an additional administration of 99mTc-Tetrofosmin resting dose if necessary.

CT stress and rest perfusion will be compared to the clinically indicated and well established SPECT examination.

Enrollment: 43 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Referral for cardiac hybrid imaging with CCTA and SPECT
• Male and Female subjects 18 years of age or older,
• Written informed consent by the participant after information about the project

Exclusion criteria

• Contraindications for CCTA (including renal failure with a GFR <60ml/min/1.73m2, allergies to ionidated constrast agents)
• Inability to follow the examination procedure due to language barriers, mental disease, dementia etc.
• Pregnancy or breast feeding
• Known allergies to iodinated contrast agent (Visipaque ®), 99mTc-Tetrofosmin (Myoview ®), betablockers (Beloc i.v. ®) or nitrates (Isoket -Spray®)
• Hypersensitivity to adenosine
• Asthma bronchiale

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

43 participants in 1 patient group

CTP and SPECT-MPI

Other group

Description:

Every patient enrolled will undergo CT-MPI and SPECT-MPI. The latter is clinically indicated,.

Treatment:

Other: CT-MPI and SPECT-MPI